Literature DB >> 11760559

NCCN: Breast cancer.

R W Carlson1, S B Edge, R L Theriault.   

Abstract

The 2001 NCCN Breast Cancer Guidelines reflect the results of 5 generations of NCCN Breast Cancer Guidelines. Evidence-based guidelines, such as the NNCN Breast Cancer Guidelines, are possible only because of the availability of high-level evidence at multiple decision points in treatment. The continued performance of high quality clinical trials is central to our ability to further improve the treatment of breast cancer. The panel believes that participation in high quality clinical trials is the preferred treatment at all points in breast cancer therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11760559

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  10 in total

1.  Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients.

Authors:  Jiayi Wu; Weiqi Gao; Xiaosong Chen; Chunxiao Fei; Lin Lin; Weiguo Chen; Ou Huang; Siji Zhu; Jianrong He; Yafen Li; Li Zhu; Kunwei Shen
Journal:  Front Med       Date:  2020-12-06       Impact factor: 4.592

2.  Adjuvant Radiation and Outcomes After Breast Conserving Surgery in Publicly Insured Patients.

Authors:  Gretchen G Kimmick; Fabian Camacho; Wenke Hwang; Heath Mackley; John Stewart; Roger T Anderson
Journal:  J Geriatr Oncol       Date:  2012-04-01       Impact factor: 3.599

3.  Racial differences in patterns of care among medicaid-enrolled patients with breast cancer.

Authors:  Gretchen Kimmick; Fabian Camacho; Kristi Long Foley; Edward A Levine; Rajesh Balkrishnan; Roger Anderson
Journal:  J Oncol Pract       Date:  2006-09       Impact factor: 3.840

Review 4.  Gene expression-based prognostic and predictive markers for breast cancer: a primer for practicing pathologists.

Authors:  Chungyeul Kim; Yusuke Taniyama; Soonmyung Paik
Journal:  Arch Pathol Lab Med       Date:  2009-06       Impact factor: 5.534

5.  Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.

Authors:  Rinaa S Punglia; Melissa E Hughes; Stephen B Edge; Richard L Theriault; Michael A Bookman; John L Wilson; Rebecca A Ottesen; Joyce C Niland; Jane C Weeks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-28       Impact factor: 7.038

6.  A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

Authors:  Laurel A Habel; Steven Shak; Marlena K Jacobs; Angela Capra; Claire Alexander; Mylan Pho; Joffre Baker; Michael Walker; Drew Watson; James Hackett; Noelle T Blick; Deborah Greenberg; Louis Fehrenbacher; Bryan Langholz; Charles P Quesenberry
Journal:  Breast Cancer Res       Date:  2006-05-31       Impact factor: 6.466

7.  Survival outcomes of different treatment methods for the ipsilateral breast of occult breast cancer patients with axillary lymph node metastasis: a single center experience.

Authors:  Sang Min Woo; Byung Ho Son; Jong Won Lee; Hee Jeong Kim; Jong Han Yu; Beom Seok Ko; Guiyun Sohn; Yu Ra Lee; Hanna Kim; Sei Hyun Ahn; Seung Hee Baek
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

8.  Spatial barriers impact upon appropriate delivery of radiotherapy in breast cancer patients.

Authors:  Fabrizio Stracci; Fortunato Bianconi; Chiara Lupi; Manuela Margaritelli; Alessio Gili; Cynthia Aristei
Journal:  Cancer Med       Date:  2018-01-22       Impact factor: 4.452

9.  Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study.

Authors:  Jaco Oosthuizen; Maritha J Kotze; Nicole Van Der Merwe; Ettienne J Myburgh; Phillip Bester; Nerina C van der Merwe
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

Review 10.  Pregnancy and breast cancer: when they collide.

Authors:  Traci R Lyons; Pepper J Schedin; Virginia F Borges
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-21       Impact factor: 2.673

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.